Mitochondrial ferritin suppresses MPTP-induced cell damage by regulating iron metabolism and attenuating oxidative stress

Brain Research

Volumn 1642, Issue , 2016, Pages 33-42

  You, Lin Hao ^a   Li, Zhen ^a   Duan, Xiang Lin ^a   Zhao, Bao Lu ^a   Chang, Yan Zhong ^a   Shi, Zhen Hua ^a  

^a HEBEI NORMAL UNIVERSITY   (China)

Author keywords

Apoptosis; Iron metabolism; Mitochondrial ferritin; MPTP; Parkinson's disease

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CD71 ANTIGEN; DOPAMINE; FERRITIN; FERROPORTIN 1; MITOCHONDRIAL FERRITIN; MITOCHONDRIAL PROTEIN; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; APOFERRITIN; CATION TRANSPORT PROTEIN; IRON; METAL TRANSPORTING PROTEIN 1; TFRC PROTEIN, MOUSE; TRANSFERRIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN LEVEL; CELL COUNT; CELL LEVEL; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONTROL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOWN REGULATION; GENE OVEREXPRESSION; HIPPOCAMPUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IRON CELL LEVEL; IRON METABOLISM; IRON STORAGE; IRON TRANSPORT; MALE; MEMBRANE STRUCTURE; METABOLIC REGULATION; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; MPTP-INDUCED PARKINSONISM; NERVE CELL; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUBSTANTIA NIGRA; UPREGULATION; ANIMAL; BRAIN; DISEASE MODEL; DRUG EFFECTS; GENETICS; INTOXICATION; KNOCKOUT MOUSE; METABOLISM; PARKINSON DISEASE;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; APOFERRITINS; APOPTOSIS; BRAIN; CATION TRANSPORT PROTEINS; CELL SURVIVAL; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; FERRITINS; HIPPOCAMPUS; IRON; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MPTP POISONING; OXIDATIVE STRESS; PARKINSON DISEASE; REACTIVE OXYGEN SPECIES; RECEPTORS, TRANSFERRIN; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 84962018674     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2016.03.023     Document Type: Article

References (32)

1. P. Arosio, R. Ingrassia, and P. Cavadini Ferritins: a family of molecules for iron storage, antioxidation and more Biochim. Biophys. Acta 1790 2009 589 599
2. S. Ayton, P. Lei, J.A. Duce, B.X. Wong, A. Sedjahtera, P.A. Adlard, A.I. Bush, and D.I. Finkelstein Ceruloplasmin dysfunction and therapeutic potential for parkinson disease Ann. Neurol. 2012
3. J.J. Bozzola Conventional specimen preparation techniques for transmission electron microscopy of cultured cells Methods Mol Biol. 1117 2014 1 19
4. A. Campanella, E. Rovelli, P. Santambrogio, A. Cozzi, F. Taroni, and S. Levi Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia Hum. Mol. Genet. 18 2009 1 11
5. B. Corsi, A. Cozzi, P. Arosio, J. Drysdale, P. Santambrogio, A. Campanella, G. Biasiotto, A. Albertini, and S. Levi Human mitochondrial ferritin expressed in HeLa cells incorporates iron and affects cellular iron metabolism J. Biol. Chem. 277 2002 22430 22437
6. B.A. Faucheux, M.T. Herrero, J. Villares, R. Levy, F. Javoy-Agid, J.A. Obeso, J.J. Hauw, Y. Agid, and E.C. Hirsch Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys Brain Res. 691 1995 115 124
7. S. Gal, H. Zheng, M. Fridkin, and M.B. Youdim Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion J. Neurochem. 95 2005 79 88
8. S. Guo, E. Bezard, and B. Zhao Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway Free Radic. Biol. Med. 39 2005 682 695
9. E.C. Hirsch Iron transport in Parkinson's disease Parkinsonism Relat. Disord. 15 Suppl. 3 2009 S209 S211
10. K.A. Jellinger The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease Drugs Aging 14 1999 115 140
11. D. Kaur, S. Rajagopalan, and J.K. Andersen Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease Brain Res. 1297 2009 17 22
12. D. Kaur, F. Yantiri, S. Rajagopalan, J. Kumar, J.Q. Mo, R. Boonplueang, V. Viswanath, R. Jacobs, L. Yang, M.F. Beal, D. DiMonte, I. Volitaskis, L. Ellerby, R.A. Cherny, A.I. Bush, and J.K. Andersen Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease Neuron 37 2003 899 909
13. T. Kitada, S. Asakawa, N. Hattori, H. Matsumine, Y. Yamamura, S. Minoshima, M. Yokochi, Y. Mizuno, and N. Shimizu Mutations in the parkin gene cause autosomal recessive juvenile Parkinsonism Nature 392 1998 605 608
14. G.C. Kost, S. Selvaraj, Y.B. Lee, D.J. Kim, C.H. Ahn, and B.B. Singh Clavulanic acid inhibits MPP (+)-induced ROS generation and subsequent loss of dopaminergic cells Brain Res. 1469 2012 129 135
15. P. Lei, S. Ayton, D.I. Finkelstein, L. Spoerri, G.D. Ciccotosto, D.K. Wright, B.X. Wong, P.A. Adlard, R.A. Cherny, L.Q. Lam, B.R. Roberts, I. Volitakis, G.F. Egan, C.A. McLean, R. Cappai, J.A. Duce, and A.I. Bush Tau deficiency induces Parkinsonism with dementia by impairing APP-mediated iron export Nat. Med. 18 2012 291 295
16. S. Levi, B. Corsi, M. Bosisio, R. Invernizzi, A. Volz, D. Sanford, P. Arosio, and J. Drysdale A human mitochondrial ferritin encoded by an intronless gene J. Biol. Chem. 276 2001 24437 24440
17. G. Nie, A.D. Sheftel, S.F. Kim, and P. Ponka Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis Blood 105 2005 2161 2167
18. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E.S. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W.G. Johnson, A.M. Lazzarini, R.C. Duvoisin, G. Di Iorio, L.I. Golbe, and R.L. Nussbaum Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
19. P. Riederer, E. Sofic, W.D. Rausch, B. Schmidt, G.P. Reynolds, K. Jellinger, and M.B. Youdim Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains J. Neurochem. 52 1989 515 520
20. P. Sangchot, S. Sharma, B. Chetsawang, J. Porter, P. Govitrapong, and M. Ebadi Deferoxamine attenuates iron-induced oxidative stress and prevents mitochondrial aggregation and alpha-synuclein translocation in SK-N-SH cells in culture Dev. Neurosci. 24 2002 143 153
21. G.P. Selvakumar, U. Janakiraman, M.M. Essa, T.A. Justin, and T. Manivasagam Escin attenuates behavioral impairments, oxidative stress and inflammation in a chronic MPTP/probenecid mouse model of Parkinson's disease Brain Res. 1585 2014 23 36
22. Z.H. Shi, G. Nie, X.L. Duan, T. Rouault, W.S. Wu, B. Ning, N. Zhang, Y.Z. Chang, and B.L. Zhao Neuroprotective mechanism of mitochondrial ferritin on 6-hydroxydopamine-induced dopaminergic cell damage: implication for neuroprotection in Parkinson's disease Antioxid. Redox Signal 13 2010 783 796
23. E. Sofic, P. Riederer, H. Heinsen, H. Beckmann, G.P. Reynolds, G. Hebenstreit, and M.B. Youdim Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain J. Neural Transm. 74 1988 199 205
24. J. Wang, N. Song, H. Jiang, J. Wang, and J. Xie Pro-inflammatory cytokines modulate iron regulatory protein 1 expression and iron transportation through reactive oxygen/nitrogen species production in ventral mesencephalic neurons Biochim. Biophys. Acta 1832 2013 618 625
25. J. Wang, H.M. Xu, H.D. Yang, X.X. Du, H. Jiang, and J.X. Xie Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins Neurochem. Int. 54 2009 43 48
26. O. Weinreb, S. Mandel, M.B. Youdim, and T. Amit Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators Free Radic. Biol. Med. 62 2013 52 64
27. F. Yantiri, and J.K. Andersen The role of iron in Parkinson disease and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine toxicity IUBMB Life 48 1999 139 141
28. M.B. Youdim M30, a brain permeable multitarget neurorestorative drug in post nigrostriatal dopamine neuron lesion of Parkinsonism animal models Parkinsonism Relat. Disord. 18 Suppl. 1 2012 S151 S154
29. X.L. Yuan, J.F. Guo, Z.H. Shi, Z.Q. Xiao, X.X. Yan, B.L. Zhao, and B.S. Tang R492X mutation in PTEN-induced putative kinase 1 induced cellular mitochondrial dysfunction and oxidative stress Brain Res. 1351 2010 229 237
30. S. Zhang, J. Wang, N. Song, J. Xie, and H. Jiang Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP (+))-induced apoptosis in MES23.5 cells Neurobiol. Aging 30 2009 1466 1476
31. Z.G. Zhang, L. Wu, J.L. Wang, J.D. Yang, J. Zhang, J. Zhang, L.H. Li, Y. Xia, L.B. Yao, H.Z. Qin, and G.D. Gao Astragaloside IV prevents MPP (+)-induced SH-SY5Y cell death via the inhibition of Bax-mediated pathways and ROS production Mol. Cell. Biochem. 364 2012 209 216
32. W. Zhu, X. Li, W. Xie, F. Luo, D. Kaur, J.K. Andersen, J. Jankovic, and W. Le Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration Neurobiol. Dis. 37 2010 307 313